EnGene Holdings Financials
| ENGNW Stock | 0.94 0.02 2.17% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.35 | 15.18 |
|
|
Investors should never underestimate EnGene Holdings' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor EnGene Holdings' cash flow, debt, and profitability to make informed and accurate decisions about investing in enGene Holdings Warrants.
Net Income |
|
EnGene | Select Account or Indicator |
Understanding current and past EnGene Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EnGene Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in EnGene Holdings' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in EnGene Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of enGene Holdings Warrants. Check EnGene Holdings' Beneish M Score to see the likelihood of EnGene Holdings' management manipulating its earnings.
EnGene Holdings Stock Summary
EnGene Holdings competes with Empresa Distribuidora, East West, CenterPoint Energy, NorthWestern, and Summit Midstream. EnGene Holdings is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | G3619H110 29286M113 |
| Location | Quebec; Canada |
| Business Address | 4868 Rue Levy, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.engene.com |
| Phone | 514 332 4888 |
EnGene Holdings Key Financial Ratios
| Return On Equity | -1.23 | ||||
| EBITDA | 62.3 M | ||||
| Net Income | (55.14 M) | ||||
| Book Value Per Share | 5.21 X | ||||
| Total Asset | 311.17 M |
EnGene Holdings Key Income Statement Accounts
The reason investors look at the income statement is to determine what EnGene Holdings' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Net Interest Income | (5.0M) | (1.3M) | (3.8M) | 7.6M | 8.8M | 9.2M | |
| Interest Income | 25K | 129K | 1.1M | 10.4M | 12.0M | 12.6M | |
| Interest Expense | 5.0M | 1.4M | 5.0M | 2.8M | 2.5M | 2.9M | |
| Operating Income | (15.9M) | (19.4M) | (26.1M) | 62.3M | 71.6M | 75.2M | |
| Research Development | 12.5M | 15.5M | 16.5M | 38.3M | 44.1M | 46.3M | |
| Ebitda | (15.7M) | (19.5M) | (94.8M) | 62.3M | 71.6M | 75.2M | |
| Income Before Tax | (23.4M) | (24.4M) | (99.9M) | 55.2M | 63.4M | 66.6M | |
| Net Income | (23.4M) | (24.5M) | (99.9M) | 55.1M | 63.4M | 66.6M | |
| Income Tax Expense | 4.9M | 22K | 17K | (19K) | (17.1K) | (16.2K) |
EnGene Holdings Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (247K) | (153K) | (318K) | (126.0M) | (113.4M) | (107.7M) | |
| Change In Cash | 6.4M | 9.4M | 61.1M | 91.5M | 105.2M | 110.5M | |
| Stock Based Compensation | 435K | 116K | 3.5M | 5.3M | 6.1M | 6.4M | |
| Free Cash Flow | (16.2M) | (17.7M) | (25.1M) | (49.2M) | (44.3M) | (42.1M) | |
| Change In Working Capital | (1.0M) | 2.2M | (517K) | 95K | 85.5K | 81.2K | |
| Begin Period Cash Flow | 4.6M | 11.0M | 20.4M | 81.5M | 93.7M | 98.4M | |
| Other Cashflows From Financing Activities | 15.4M | (423K) | (4.0M) | (7.5M) | (6.7M) | (6.4M) | |
| Depreciation | 272K | 238K | 175K | 91K | 81.9K | 77.8K | |
| Other Non Cash Items | 5.0M | 370K | 72.1M | 1.4M | 1.7M | 1.6M | |
| Capital Expenditures | 248K | 153K | 318K | 925K | 1.1M | 1.1M | |
| Total Cash From Operating Activities | (16.0M) | (17.6M) | (24.7M) | (48.3M) | (43.5M) | (41.3M) | |
| Net Income | (23.4M) | (24.5M) | (99.9M) | (55.1M) | (49.6M) | (52.1M) | |
| Total Cash From Financing Activities | 22.5M | 28.0M | 86.1M | 265.7M | 305.6M | 320.9M | |
| End Period Cash Flow | 11.0M | 20.4M | 81.5M | 173.0M | 199.0M | 208.9M |
EnGene Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EnGene Holdings's current stock value. Our valuation model uses many indicators to compare EnGene Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EnGene Holdings competition to find correlations between indicators driving EnGene Holdings's intrinsic value. More Info.enGene Holdings Warrants is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, EnGene Holdings' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value EnGene Holdings by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.enGene Holdings Warrants Systematic Risk
EnGene Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. EnGene Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on enGene Holdings Warrants correlated with the market. If Beta is less than 0 EnGene Holdings generally moves in the opposite direction as compared to the market. If EnGene Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one enGene Holdings Warrants is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of EnGene Holdings is generally in the same direction as the market. If Beta > 1 EnGene Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as EnGene Holdings is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of EnGene has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if EnGene Holdings' financials are consistent with your investment objective using the following steps:- Review EnGene Holdings' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand EnGene Holdings' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare EnGene Holdings' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if EnGene Holdings' stock is overvalued or undervalued.
Today, most investors in EnGene Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various EnGene Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of EnGene Holdings growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
EnGene Holdings January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of EnGene Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of enGene Holdings Warrants. We use our internally-developed statistical techniques to arrive at the intrinsic value of enGene Holdings Warrants based on widely used predictive technical indicators. In general, we focus on analyzing EnGene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build EnGene Holdings's daily price indicators and compare them against related drivers.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 49.87 | |||
| Value At Risk | (17.44) | |||
| Potential Upside | 18.31 |
Additional Tools for EnGene Stock Analysis
When running EnGene Holdings' price analysis, check to measure EnGene Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnGene Holdings is operating at the current time. Most of EnGene Holdings' value examination focuses on studying past and present price action to predict the probability of EnGene Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnGene Holdings' price. Additionally, you may evaluate how the addition of EnGene Holdings to your portfolios can decrease your overall portfolio volatility.